<analysis>
**Action 1 (3-seed readout).** The run is already trained, so the remaining work is analysis, not compute. That removes the failure mode behind most of the eight earlier misses, but three risks remain.
- **Execution risk.** Independent evaluators must run the registered analysis, the concealed-identity slice and the awareness probes within about 17 days. The resume-quarantine bug may have left shard provenance ambiguous for the seeds that were preempted. The slice is new instrumentation and has never been run.
- **Staff pulls.** Threat 1 models this separately, so it is excluded here.
- **Likely result.** At an MDE of about +5.2, "inconclusive" is the probable scientific outcome, and that still counts as a delivered readout.

**Action 2 (branch start).** The start needs a readout by 20 February, CEO sign-off, and a reservation that survives the point release.
- The CEO has kept his override and has watched this line slip into "Q1" twice. Board authorization raises the chance of sign-off, but it does not guarantee it.
- An inconclusive readout gives the CEO grounds to delay.
- Holding a March reservation in place during a competitive release is hard.
- The external-continuation fallback depends on counsel, which moves slowly.

**Action 3 (OLMo-3 paired job).** The partner has committed compute and evaluators, so the start is the partner's own action.
- Risks: package or version drift, the scope question of adding behavioural measurement, and resume issues like those Anthropic hit in January.
- Google naming a training owner within the sprint is unlikely, at about 20%.
- A commitment to an April recipe decision is unlikely at an outside institution.

**Action 4 (containment).** Moving from 41% to 55% of high-consequence actions in one month is about 3.5 times last month's gain. The ransomware story creates some demand pull, but a point release competes for platform staff. The delegated-chain fix is real engineering; the retest outcome is modelled in Threat 3.

**Action 5 (workers).** 80 confirmed remedies is four times January's 19, and the new hire starts only on 10 February. Net reduction of the backlog is plausible; hitting 80 is not. The foundation outcome is Threat 5.

**Action 6 (March decision package).** Assembling the package from cleared material is routine. Named sponsors are likely for at most one or two components; Cruz and the CR crowd the agenda. NY ITS round three is slow.

**Calendar and exogenous items, priced now**

| Item | Probability |
|---|---|
| BIS IFR comment window closes on schedule | 95% |
| Understaffed-site hire starts 10 Feb | 85% |
| Google sprint actually starts in February | 85% |
| OLMo-3 job starts by 12 Feb | 80% (inside Action 3) |
| Anthropic point release ships in February | 55% (by March: 85%) |
| Checked 3-seed readout delivered by 20 Feb | ~55% (Action 1 success × no Threat 1) |
| CEO signs off, given an on-time readout | 60% (lower if Threat 2 fires) |
| Harrow retest completed in February | 60% |
| NY ITS signs terms | 15% |
| Hospital consortium substantive reply | 25% |
| Foundation decides at its February meeting rather than deferring again | 80% |
| January jobs report (6 Feb) shows net loss | 70% |
| Grok 5 public release in February | 15% |
| CISA or congressional inquiry to closed labs on agent-enforcement coverage, following the ransomware attribution | 30% |
| Measurable inbound customer demand for Anthropic enforcement or point-of-effect services citing V6 | 60% |
| Further publicly attributed V6-scaffold incident | 35% |
| AISI reciprocal exercise scheduled | 10% |

**Capability clock.** The index should rise 0.15–0.20, to about 9.27–9.32. The drivers are Gemini DRA usage data, Abilene iteration and V6 open fine-tunes.
</analysis>

<action_odds>
Action 1 [3-seed readout by 18–20 Feb]: P(failure) 30%. Reason: This is analysis only, with no training needed, which removes the main failure mode of past months. Residual risk comes from shard provenance after the quarantine bug, the never-run concealed-identity slice and a tight 17-day window. Staff pulls are left to Threat 1.

Action 2 [CEO sign-off and branch start by 21 Feb]: P(failure) 50%. Reason: The start depends on Action 1's readout (a missing prerequisite caps it), on the CEO who retains an override and deferred twice, and on a reservation surviving a point release. The board authorization helps. The external-continuation fallback cannot be decided within the month.

Action 3 [AISI-partner OLMo-3 job plus Google offer]: P(failure) 25%. Reason: The partner has committed its own compute and evaluators. Integration or resume problems are the main risks. Google naming a training owner (~20%) and an April decision commitment are low-probability upside, not conditions for success.

Action 4 [delegated-cancellation fix, 55% coverage]: P(failure) 45%. Reason: A 14-point jump in coverage is about 3.5 times last month's gain, and the point release competes for staff. Ransomware-driven demand helps somewhat. The retest outcome sits in Threat 3.

Action 5 [backlog recovery, 80 remedies]: P(failure) 60%. Reason: The target is four times January's rate, and the hire starts mid-month. A net backlog reduction is plausible; hitting the full target is unlikely. Funding is left to Threat 5.

Action 6 [March decision package with owners]: P(failure) 30%. Reason: It uses already-cleared material through existing consultations. Named sponsors are likely for only one or two components, and NY ITS remains slow.
</action_odds>

<threat_odds>
Threat 1 [point release eats the gate]: P(materialises) 30%. Adversary suggested 35%; reason for any difference: Launches pulled alignment staff three months running, and the release is 55% likely in February. Analysis needs fewer people than training, and the board deadline gives the request for protection more weight.

Threat 2 [readout exposes awareness-tracking recipe]: P(materialises) 20%. Adversary suggested 25%; reason for any difference: It requires an on-time readout and a slice result strong enough to read as reversal. At three seeds, noise more likely yields an ambiguous slice than a clear reversal, but 23% evaluation awareness makes the mechanism real.

Threat 3 [cancellation retest fails / executive exception]: P(materialises) 35%. Adversary suggested 40% (15% for the exception); reason for any difference: Multi-agent recall is genuinely hard and one revocation step depends on a vendor, but the fix is targeted at the known leak. The split is 32% retest fails or is incomplete and 8% executive exception, since the existing Harrow hold makes an exception costly.

Threat 4 [ungated rival jump]: P(materialises) 20%. Adversary suggested 30%; reason for any difference: Grok 5 has been in training for a long time but has no signalled date (15% for release this month). An Abilene point update claiming more than 82% without pre-release access in the same month is less likely. Some capability gain happens regardless on the index path.

Threat 5 [foundation declines or shrinks the $1.0M]: P(materialises) 45%. Adversary suggested 45%; reason for any difference: This matches the adversary. The earlier deferral over thin verification, 19 confirmed remedies, and two negative stories make a decline or reduction roughly a coin flip.
</threat_odds>
